Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 37R35 | IM / RA |
Patient experienced swelling at injection site. Cold compress applied. Patient monitored for 30 minutes and advised to follow up with his PCP. No further adverse effects experienced.
NKA